Page last updated: 2024-09-03

angiotensin ii, des-phe(8)- and triiodothyronine

angiotensin ii, des-phe(8)- has been researched along with triiodothyronine in 2 studies

Compound Research Comparison

Studies (angiotensin ii, des-phe(8)-)	Trials (angiotensin ii, des-phe(8)-)	Recent Studies (post-2010) (angiotensin ii, des-phe(8)-)	Studies (triiodothyronine)	Trials (triiodothyronine)	Recent Studies (post-2010) (triiodothyronine)
1,533	21	995	26,247	861	3,473

Protein Interaction Comparison

Protein	Taxonomy	triiodothyronine (IC50)
Thyroid hormone receptor alpha	Homo sapiens (human)	0.0006
Thyroid hormone receptor beta	Homo sapiens (human)	0.0006
Proliferating cell nuclear antigen	Homo sapiens (human)	3.6
Thyroid hormone receptor beta	Rattus norvegicus (Norway rat)	0.0031
Adenosine receptor A1	Homo sapiens (human)	0.4109

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Barreto-Chaves, MLM; Campagnole-Santos, MJ; Diniz, GP; Melo, MB; Santos, RAS; Senger, N	1
Akamine, EH; Barreto-Chaves, MLM; C Parletta, A; Campagnole-Santos, MJ; Diniz, GP; Marques, BVD; Santos, RAS; Senger, N	1

Other Studies

2 other study(ies) available for angiotensin ii, des-phe(8)- and triiodothyronine

Article	Year
Angiotensin-(1-7) reduces cardiac effects of thyroid hormone by GSK3Β/NFATc3 signaling pathway. Clinical science (London, England : 1979), 2018, 06-14, Volume: 132, Issue:11 Topics: Angiotensin I; Animals; Cardiomegaly; Cells, Cultured; Echocardiography; Glycogen Synthase Kinase 3 beta; Hyperthyroidism; Male; Myocytes, Cardiac; NFATC Transcription Factors; Peptide Fragments; Rats, Sprague-Dawley; Rats, Transgenic; Rats, Wistar; Renin-Angiotensin System; Signal Transduction; Triiodothyronine	2018
Angiotensin-(1-7) prevents T3-induced cardiomyocyte hypertrophy by upregulating FOXO3/SOD1/catalase and downregulating NF-ĸB. Journal of cellular physiology, 2021, Volume: 236, Issue:4 Topics: Angiotensin I; Animals; Antioxidants; Catalase; Down-Regulation; Forkhead Box Protein O3; Hypertrophy; Male; Models, Biological; Myocytes, Cardiac; NF-kappa B; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats, Sprague-Dawley; Rats, Transgenic; Rats, Wistar; Reactive Oxygen Species; Receptors, G-Protein-Coupled; Superoxide Dismutase-1; Triiodothyronine; Up-Regulation	2021

Article

Year

Angiotensin-(1-7) reduces cardiac effects of thyroid hormone by GSK3Β/NFATc3 signaling pathway.

Clinical science (London, England : 1979), 2018, 06-14, Volume: 132, Issue:11

Topics: Angiotensin I; Animals; Cardiomegaly; Cells, Cultured; Echocardiography; Glycogen Synthase Kinase 3 beta; Hyperthyroidism; Male; Myocytes, Cardiac; NFATC Transcription Factors; Peptide Fragments; Rats, Sprague-Dawley; Rats, Transgenic; Rats, Wistar; Renin-Angiotensin System; Signal Transduction; Triiodothyronine

2018

Angiotensin-(1-7) prevents T3-induced cardiomyocyte hypertrophy by upregulating FOXO3/SOD1/catalase and downregulating NF-ĸB.

Journal of cellular physiology, 2021, Volume: 236, Issue:4

Topics: Angiotensin I; Animals; Antioxidants; Catalase; Down-Regulation; Forkhead Box Protein O3; Hypertrophy; Male; Models, Biological; Myocytes, Cardiac; NF-kappa B; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats, Sprague-Dawley; Rats, Transgenic; Rats, Wistar; Reactive Oxygen Species; Receptors, G-Protein-Coupled; Superoxide Dismutase-1; Triiodothyronine; Up-Regulation

2021